NeoGenomics, Inc.
(NASDAQ : NEO)

( )
NEO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
GHGuardant Health, Inc. 11.63%43.000.0%$96.03m
LHCGLHC Group, Inc. 0.46%166.983.0%$87.83m
DNAGinkgo Bioworks Holdings, Inc. 7.94%3.200.0%$76.75m
DVADaVita, Inc. 0.21%97.654.1%$73.27m
NTRANatera, Inc. 5.29%41.191.1%$64.92m
AZTAAzenta, Inc. 6.13%77.770.0%$48.64m
ACHCAcadia Healthcare Co., Inc. 0.51%72.2926.6%$45.22m
AGLAgilon Health, Inc. 2.76%19.750.0%$43.31m
AMEDAmedisys, Inc. 0.12%117.5311.4%$39.77m
NVTAInvitae Corp. 15.00%4.031.1%$38.26m
OSHOak Street Health, Inc. 7.10%19.550.0%$37.38m
TVTYTivity Health, Inc. 0.00%32.318.8%$30.11m
OPCHOption Care Health, Inc. 6.43%30.940.0%$28.22m
NUTXNutex Health, Inc. 0.91%10.000.0%$25.81m
FLGTFulgent Genetics, Inc. 3.72%57.980.6%$24.25m

Company Profile

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.